We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

664 hedge funds and large institutions have $10.8B invested in Charles River Laboratories in 2024 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 266 increasing their positions, 235 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 266 | Existing positions reduced: 235

0.06% less ownership

Funds ownership: 101.79% → 101.73% (-0.06%)

6% less first-time investments, than exits

New positions opened: 74 | Existing positions closed: 79

2% less funds holding

Funds holding: 676 → 664 (-12)

15% less call options, than puts

Call options by funds: $54.2M | Put options by funds: $63.4M

23% less capital invested

Capital invested by funds: $14.1B → $10.8B (-$3.32B)

47% less funds holding in top 10

Funds holding in top 10: 15 → 8 (-7)

Holders
664
Holders Change
-12
Holders Change %
-1.78%
% of All Funds
9.59%
Holding in Top 10
8
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-46.67%
% of All Funds
0.12%
New
74
Increased
266
Reduced
235
Closed
79
Calls
$54.2M
Puts
$63.4M
Net Calls
-$9.19M
Net Calls Change
+$37.2M

Top Buyers

1
SCA
Southpoint Capital Advisors
New York
+$102M
2
Marshall Wace
Marshall Wace
United Kingdom
+$36.9M
3
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$36.3M
4
MDSL
M.D. Sass LLC
New York
+$36.1M
5
Allspring Global Investments
Allspring Global Investments
North Carolina
+$30.1M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$154M
2
MBI
Montrusco Bolton Investments
Quebec, Canada
-$133M
3
William Blair Investment Management
William Blair Investment Management
Illinois
-$98.8M
4
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$43.3M
5
ClearBridge Investments
ClearBridge Investments
New York
-$32.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
RS
651
Rakuten Securities
Japan
$620 +$227 +1 +50%
RCM
652
Raleigh Capital Management
North Carolina
$620 +$227 +1 +50%
BHWM
653
Beaird Harris Wealth Management
Texas
$620 +$680 +3 New
OWA
654
Opal Wealth Advisors
New York
$620 +$680 +3 New
TCG
655
Transcendent Capital Group
Oklahoma
$620 +$680 +3 New
UWS
656
Unique Wealth Strategies
Illinois
$542 +$453 +2 New
ECM
657
Everence Capital Management
Indiana
$366 – – –
AWM
658
Abound Wealth Management
Tennessee
$255 – – –
WA
659
WestEnd Advisors
North Carolina
$207 – – –
CWC
660
Carolinas Wealth Consulting
North Carolina
$207 +$227 +1 New
FNWA
661
Financial Network Wealth Advisors
Utah
$207 +$227 +1 New
KFI
662
Key Financial Inc
Pennsylvania
$207 +$227 +1 New
NL
663
NVWM LLC
Pennsylvania
$207 +$227 +1 New
MBI
664
Montrusco Bolton Investments
Quebec, Canada
– -$133M -489,751 Closed
William Blair Investment Management
665
William Blair Investment Management
Illinois
– -$98.8M -364,614 Closed
IHAM
666
Integral Health Asset Management
New York
– -$17.6M -65,000 Closed
WA
667
Watchtower Advisors
Connecticut
– -$10.9M -40,300 Closed
Holocene Advisors
668
Holocene Advisors
New York
– -$8.69M -32,078 Closed
GAA
669
Global Assets Advisory
Florida
– -$114K -30,635 Closed
SGH
670
Sivik Global Healthcare
Connecticut
– -$6.77M -25,000 Closed
CCM
671
Cinctive Capital Management
New York
– -$5.78M -21,329 Closed
RCM
672
Regency Capital Management
Hawaii
– -$4.86M -17,930 Closed
PHP
673
Parkman Healthcare Partners
Connecticut
– -$4.8M -17,697 Closed
WP
674
Woodline Partners
California
– -$4.55M -16,780 Closed
RA
675
Royce & Associates
New York
– -$4.22M -15,592 Closed
25 26
27
28 29

CRL Hedge Fund Activity: Q2 2024 in Review

664 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2024, worth a combined $10.8B — down 23% from $14.1B a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of CRL and 74 opened new positions — a net loss of 5 holders — while 235 trimmed existing stakes and 266 added.

The largest buyer was Southpoint Capital Advisors, adding an estimated $102M. The largest seller was T. Rowe Price Associates, cutting an estimated $154M.

  • 664 institutional investors held Charles River Laboratories (CRL) as of Q2 2024, down from 676 in Q1 2024.
  • Funds reported $10.8B of Charles River Laboratories stock for Q2 2024, down 23% quarter-over-quarter.
  • 74 funds opened new Charles River Laboratories positions in Q2 2024 and 79 closed out, a net change of -5 holders.
  • The largest Charles River Laboratories buyer in Q2 2024 was Southpoint Capital Advisors, an estimated $102M added.
  • The largest Charles River Laboratories seller in Q2 2024 was T. Rowe Price Associates, an estimated $154M sold.

Based on aggregated 13F filings for Q2 2024.